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Assessing procedural pain in infants: a feasibility study 
evaluating a point-of-care mobile solution based on 
automated facial analysis
Kreshnik Hoti, Paola Teresa Chivers, Jeffery David Hughes
Summary
Background The management of procedural pain in infants is suboptimal, in part, compounded by the scarcity of a 
simple, accurate, and reliable method of assessing such pain. In this study, we aimed to evaluate the psychometric 
properties of the PainChek Infant, a point-of-care mobile application that uses automated facial evaluation and 
analysis in the assessment of procedural pain in infants.
Methods Video recordings of 40 infants were randomly chosen from a purposely assembled digital library of 
410 children undergoing immunisation as part of their standard care in Prishtina, Kosovo, between April 4, 2017, 
and July 11, 2018. For each infant recording, four 10 s video segments were extracted, corresponding to baseline, 
vaccine preparation, during vaccination, and recovery. Four trained assessors did pain assessments on the video 
segments of 30 infants, using PainChek Infant standard, PainChek Infant adaptive, the Neonatal Facial Coding 
System-Revised (NFCS-R) single, the NFCS-R multiple, and the Observer administered Visual Analogue Scale 
(ObsVAS), on two separate occasions. PainChek Infant’s performance was compared to NFCS-R and ObsVAS using 
correlation in changes in pain scores, intra-rater and inter-rater reliability, and internal consistency.
Findings 4303 pain assessments were completed in two separate testing sessions, on Aug 31, and Oct 19, 2020. The 
study involved videos of 40 infants aged 2·2–6·9 months (median age 3·4 months [IQR 2·3–4·5]). All pain assessment 
tools showed significant changes in the recorded pain scores across the four video segments (p≤0·0006). All tools 
were found to be responsive to procedure-induced pain, with the degree of change in pain scores not influenced by 
pre-vaccination pain levels. PainChek Infant pain scores showed good correlation with NFCS-R and ObsVAS scores 
(r=0·82–0·88; p<0·0001). PainChek Infant also showed good to excellent inter-rater reliability (ICC=0·81–0·97, 
p<0·001) and high levels of internal consistency (α=0·82–0·97).
Interpretation PainChek Infant’s use of automated facial expression analysis could offer a valid and reliable means of 
assessing and monitoring procedural pain in infants. Its clinical utility in clinical practice requires further research.
Funding PainChek.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Procedural pain is acute pain associated with 
investigations, treatments, or procedures done in the 
course of delivering health care.1,2 As such, pain can arise 
from any procedure causing actual or potential tissue 
damage.1 Such interventions include simple procedures 
such as intravenous cannulation, venepuncture, finger 
and heel pricks, immunisations, and dressing changes, 
to more invasive procedures such as lumbar punctures 
or bone marrow biopsies.1,2 Procedures occur in a variety 
of settings, from hospitals or day surgery centres to 
ambulatory care clinics, general practice, dental clinics, 
and the home care environment.1
Although procedural pain might be associated with an 
isolated event, it is not uncommon for children to have 
multiple painful procedures daily when being cared for 
in hospital or ambulatory settings.3 Within emergency 
departments, procedures represent one of the most 
common sources of acute painful stimulus in children, 
with studies showing up to 80% of children undergoing 
painful diagnostic procedures.4 Unfortunately, there 
are numerous studies reporting that pain, especially 
procedural pain, in children including infants, is often 
poorly managed.3,5 These findings are despite the 
optimisation of the management of paediatric pain being 
a key health-care priority of WHO and leading paediatric 
and pain societies.3
Poorly managed procedural pain can have short-term 
and long-term consequences.1,5 Repeated procedures 
warrant careful pain management as insufficient pain 
relief could lead to anxiety and distress during 
subsequent episodes.3,5,6 In infants, a major challenge to 
managing pain is the ability to assess it accurately and 
reliably. The generally accepted standard for pain 
assessment is self-report; however, in preverbal children 
who cannot communicate their pain, age-appropriate 
behavioural or observational pain assessment tools are 
recommended.6
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Common to the multitude of existing observational 
pain assessment tools is the evaluation of the child’s facial 
expression.7 However, as a result of practical difficulties 
with manual decoding of facial expressions, automated 
facial expression analysis is a topic of broad research.8 In 
children, there have been a number of studies exploring 
automated pain facial expression recognition.8,9 However, 
we are not aware of any automated pain assessment tools 
for infants that have been tested against existing paper-
based validated tools and that are available for use at 
point-of-care in a mobile application (app).
The aim of this study was to evaluate the psychometric 
properties of the PainChek Infant, a point of care app 
that utilises automated facial expression analysis to 
detect pain in infants aged 1–12 months, against two 
scales: the Neonatal Facial Coding System (NFCS),10–14 
which has been designed for procedural pain assessment, 
and the Observer administered Visual Analogue Scale 
(ObsVAS) pain scale, which is used to quantify procedural 
pain intensity. In doing so, we question whether it is 
feasible to use the automated facial expression analysis 
of PainChek Infant to detect and quantify pain.
Methods
Study design and population
In this feasibility study, we evaluated the PainChek Infant 
against the Neonatal Facial Coding System-Revised 
(NFCS-R) and the ObsVAS to investigate whether 
PainChek’s automated facial expression analysis on a 
series of videos of infants undergoing immunisation can 
accurately detect and quantify pain. The infant videos 
used in this study came from a purposely assembled 
digital library of children undergoing routine immu-
nisation at an immunisation clinic in Prishtina, Kosovo. 
The parents or guardians of the children provided 
informed written consent for their child’s immunisation 
Research in context
Evidence before this study
In this study, we aimed to validate a novel pain assessment tool 
for infants, PainChek Infant. Initially, we reviewed currently 
available evidence on pain assessment tools in infants. In doing 
so, we searched the following databases: MEDLINE, Embase, 
PsycInfo, and Joanna Briggs Institute Database from inception 
through to Oct 31, 2020, using keywords agreed between three 
reviewers ([“infant”, “pain measurement”, “pain assessment”, 
“pain scale”, or “rating pain”], with [“review”, “systematic 
review”, or “meta-analysis”]). We also individually searched 
leading paediatric journals. Our key criteria for literature 
selection related to identifying and reviewing currently 
available systematic reviews that reported pain assessment in 
infants, and were available in English. PRISMA protocol was 
consulted in reviewing the relevant literature. Following the 
literature search, we selected the records which fulfilled our 
criteria and conducted a qualitative analysis of the full papers. 
We concluded that there are over 40 pain assessment tools that 
have been developed thus far that are based around observer 
identification and evaluation of specific biomarkers indicative 
of pain. However, to our knowledge there is no automated pain 
assessment tool used in infants. All currently available tools rely 
on users making their decisions based on subjective 
observations of the child. Furthermore, our review of the 
literature showed that the presence of so many pain 
assessment tools for infants is marred by an absence of 
universal standardisation, which has resulted in a variety of 
criteria being used by clinicians in order to assess pain in 
infants. In practice, this could result in variation in 
interpretations of the presence and intensity of pain, 
which could go on to have an effect on how pain is treated.
Added value of this study
This study describes the evaluation of the psychometric 
properties of a technology-based solution for the assessment of 
procedural pain in infants. PainChek Infant uses automated 
facial evaluation and analysis to detect six facial action units 
(AUs) indicative of the presence of pain. In this study, 
we showed that, when compared to manual assessment using 
either the Neonatal Facial Coding System-Revised (a validated 
facial action recognition tool based observational pain 
assessment) or an observer administered Visual Analogue Scale, 
PainChek Infant showed moderate to excellent validity, 
inter-rater and intra-rater reliability, and internal consistency. 
Further, in accordance with previous research, the AUs detected 
represent pain intensity and pain-related distress. Using 
automated facial evaluation and analysis PainChek Infant 
provides a rapid (assessments take 3 s), valid, and reliable 
means of assessing procedural pain.
Implications of all the available evidence
Although there are currently many available tools to assess 
procedural pain in infants, they are often underused and, as a 
result, infants continue to undergo painful procedures without 
adequate pain management, resulting in short-term and long-
term negative outcomes. Artificial intelligence in this field can be 
used to support clinician decision making, allow curiosity-driven 
care, remove the need to complete mundane tasks, improve 
communication, and facilitate collaboration. Evaluation of the 
face is central to all observational pain assessment tools, as the 
face is highly accessible and facial expressions are considered the 
most encodable feature of pain. However, decoding of the face by 
clinicians and parents alike is difficult when trying to discern pain 
from other causes of distress. It is therefore important that new 
tools developed to assess pain in this vulnerable population take 
advantage of technology to objectify and simplify the process, 
thus allowing users to better identify and quantify pain. This 
study adds to the body of evidence to support the use of artificial 
intelligence in the assessment of pain in the infant population, 
and its advantages over humans in decoding pain behaviours.
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to be video recorded and used for research and 
development purposes. The digital library consisted of 
410 children aged 0–12 years, of whom 329 were infants. 
After reviewing these infant videos for suitability, on the 
basis of the infant’s face not being obstructed from view, 
we randomly chose 40 of them, using an electronic 
randomiser. In cases when there was a substantial 
obstruction, the next video in line was chosen. Each 
infant was recorded for approximately 60 s before and 
90 s after the vaccination. This study was approved by 
human research ethics committees of the Faculty of 
Medicine, University of Prishtina, Kosovo (approval 
number: 3812/17) and Curtin University, Perth, WA, 
Australia (approval number: HRE2020-0315).
Procedures
PainChek Infant uses artificial intelligence (AI) for the 
automated recognition and analysis of an infant’s face, 
allowing detection of six facial action units (AUs) 
indicative of the presence of pain: AU4 (brow lowering), 
AU9 (wrinkling of nose), AU15 (lip corner depressor), 
AU20 (horizontal mouth stretch), AU25 (parting lips), 
and AU43 (eye closure). These facial actions represent 
specific muscle movements (contractions or relaxations) 
as classified by the Baby Facial Action Coding System.13 
Each of the six AUs is scored using a binary scale 
(0=absent, 1=present), yielding a total potential score 
of 6. The tool has been specifically designed to assess 
pain in infants (aged 1–12 months), taking into account 
the facial actions commonly associated with pain in 
this population. The algorithms created during the 
PainChek Infant development were trained on images 
corresponding to this age group. The algorithms for 
the app were developed by data scientists from the 
Universida de Castilla-La Mancha, Spain, using a non-
proprietary database of videos of infants undergoing 
routine immunisations. A five-fold cross validation 
methodology was used, using independent training 
and validation datasets. The automated facial analysis 
could be completed either using a fixed video duration 
(standard 3 s video mode) or using a fixed number of 
minimum valid images (video adaptive mode). The 
video adaptive mode has been developed to address the 
potential for increased head movements that often 
accompany pain or distress in infants.
The NFCS-R, one of the two PainChek Infant com-
parators in this study, utilises the same construct as 
PainChek Infant in that it uses facial actions as indicators 
of pain, but is assessor-rated rather than automated. The 
original NFCS contained ten facial actions; however, a 
1996 study showed that reducing the detection of facial 
actions to five improved the specificity for pain assessment, 
while maintaining sensitivity and validity.15 The NFCS-R 
contains the following five facial actions:14 brow bulge, eye 
squeeze, nasolabial furrow, horizontal mouth stretch, and 
taut tongue. The scoring system in the NFCS-R is also 
binary, with final pain score between 0 and 5 depending 
on the presence of each of the above facial actions. The 
NFCS has been used and evaluated in procedural pain16 
and postoperative pain15 in infants and it can evaluate the 
effect of treatment, as well as discriminate between tissue 
insult and non-tissue insult procedures.13,15,16 Overall, 
the NFCS has been shown to have good inter-rater 
reliability,14,17–19 construct validity,13,15,16 and convergent 
validity.18,19 More details on the characteristics of the 
NFCS-R have been published elsewhere.14
The ObsVAS, the second PainChek Infant comparator, 
is a commonly used tool that measures and quantifies 
pain and distress.20 The scale consists of a 100 mm line 
on which 0 mm represents no pain or distress and 
100 mm represents the worst possible pain or distress. 
The level of pain or distress is determined by the distance 
from the 0 mm point. The ObsVAS scale was included to 
gain an estimate of the level of pain or distress that 
assessors perceived the infant to be experiencing during 
the phases of the procedure. A 2009 study reported 
ObsVAS to have good-to-excellent intra-rater reliability 
(intraclass correlation coefficient [ICC] 0·69 to 0·91) and 
inter-rater reliability (ICC 0·55 to 0·97), and strong 
criterion validity compared with the Modified Behavioural 
Pain Scale (Pearson’s rho 0·81–0·94) in infants under-
going vaccination.20
The video recordings for each of the 40 infants were 
divided into segments to show different phases of the 
procedure: baseline (before any attempt to prepare the 
infant for the procedure was made [ie, while still in their 
parent’s arms]), preparation (while the infant’s arm was 
prepared and swabbed), during vaccination (the painful 
part of the procedure [ie, the 10 s after needle insertion]), 
recovery (after the painful procedure [ie, between 10 s 
and 40 s after the needle insertion). It was presumed that 
any behavioural change suggestive of distress in the 
infant in baseline and preparation segments was most 
likely non-pain related, as these infants were yet to have 
their injection. 160 video segments were prepared for 
review. Each video segment was 10 s in length (the first 
10 s segment without substantial obstruction was chosen) 
as required for NFCS-R video analysis.12
Four assessors used the three pain assessment 
instruments to assess the pain or distress experienced by 
the infant. Assessors were blinded to each other’s results 
and did their assessments and data entry remotely via 
a purposefully designed electronic data management 
system (EDMS, version 1). The assessors accessed the 
EDMS with their unique study identification number to 
ensure that they only assessed the infants allocated to 
them. Every assessor was assigned 120 video segments on 
which to do the pain assessments, from one of two testing 
session sets. Each video testing set included 30 infants, 
chosen from the pool of 40 infants, ten of whom were 
unique to that testing session set. This assignment 
method ensured independent, paired pain assessments 
were completed by at least two assessors on each video 
segment. Each testing session dataset was assigned to 
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one clinically experienced assessor (ie, paediatric nurses) 
and one clinically naive assessor (ie, nursing students 
who have not yet started their paediatric placements). 
To minimise recall bias, each assessor completed two 
separate testing sessions 4 weeks apart. PainChek Infant 
facial assessments were completed using version 1.3 
(V17) installed onto an iPad Mini-4 (Cupertino, CA, USA, 
IOS version 13.6.1). The NFCS-R was incorporated into 
the EDMS so that facial actions observed could be entered 
whilst the assessors watched the video segments, and a 
slider bar was incorporated into the EDMS so that the 
assessor could directly enter their ObsVAS scores. Results 
obtained from the three pain assessment scales were 
entered into the EDMS. In case of PainChek Infant, after 
recording the data, the assessment was cancelled in 
the app so that the results were not retained on the device.
During the first testing session, the video segments, 
without audio, were loaded into the EDMS for the assessor 
to view and record their results. Assessors were required 
to complete their pain assessments using the tools in 
this order: NFCS-R single video viewing (NFCS-R single), 
NFCS-R multiple video viewing (NFCS-R multiple), 
ObsVAS, PainChek Infant video adaptive mode (PainChek 
Infant adaptive), and PainChek Infant standard 3 s video 
mode (PainChek Infant standard). This order was chosen 
to minimise bias that could occur by using automatic 
PainChek Infant before other tools that require assessor 
rating. However, the order in which the 30 subjects 
appeared in both testing session sets was randomly 
allocated by the research team. All four video segments of 
each of the 30 infants was assessed using the same tool, 
and once the assessment of all four video segments was 
completed for an individual infant and submitted into the 
EDMS, they could no longer be viewed by the assessor. 
This approach was adopted to reduce recall bias. After 
completing assessments of all the videos in their testing 
session set using one tool, the assessors repeated the 
assessments using the next allocated tool. To further avoid 
recall bias, the order in which video segments were 
presented for assessment was automatically and randomly 
assigned by the EDMS for each pain assessment method. 
In the second testing session, 4 weeks later, each assessor 
completed assess ments for the same video segments as 
they had done in the first testing session, without access to 
their previous results. In the second testing session, 
assessors did not repeat the PainChek Infant assessments, 
rather these assessments were completed independently 
through a PainChek Infant simulator.
To ensure competency in the use of the pain assessment 
tools, assessors were required to complete training in the 
use of PainChek Infant, the NFCS-R,12 and ObsVAS 
before data collection began. The assessors were also 
familiarised with the use of the EDMS.
Statistical analysis
The sample size was based on a minimum of five patients 
needed to evaluate every item included in the tool.21 As the 
PainChek Infant facial domain has six items, a minimum 
sample size of 30 was necessary. For practical reasons, a 
sample of 40 was chosen to allow instances in which 
matched pain assessments could not be completed (eg, if 
the automated facial analysis failed after two attempts).
IBM SPSS Statistics version 26 was used for the 
data analysis, unless otherwise stated, with statistical 
significance set at p<0·05, two-tailed. PainChek Infant 
results were described using frequency and percentage. 
A binomial logit link generalised linear mixed model 
(GLMM) assessed each facial action (dependent outcome) 
with video segments (baseline, preparation, during, 
recovery), assessors (fixed factor), and infants treated as a 
random factor (see appendix p 1 for model specifications).
Pain and distress scores were not normally distributed, 
as assessed by a Kolmogorov-Smirnov normality test. 
Pain and distress scores were described using mean, SD, 
median, and IQR for all assessment methods and video 
segments. A gamma distribution with log link generalised 
estimating equation (GEE) model was used to examine 
any differences in pain scores across video repeats, 
controlling for repeated infant, video segment, assessor, 
and repeat occasion (see appendix p 1). For all GEE 
models, test of model effects (Wald [χ²]), parameter 
estimates, and Bonferroni corrected pairwise comparisons 
were reported.
A change score was calculated to assess the respon-
siveness of the scales to change. The painful procedure 
change score was calculated for each method by 
computing the pain score during vaccination minus the 
baseline score. The non-painful procedure change score 
was calculated for each method by computing the pain 
score at preparation minus the baseline score. Painful and 
non-painful change scores were described using mean, 
SD, 95% bias corrected and accelerated (BCa) confidence 
intervals (CI). BCa CI were computed using 1000 samples 
with sampling stratified on assessors. We considered 
responsiveness shown if the change in scores was more 
than 2 points for PainChek Infant methods, or more than 
33% for alternative methods, and the rationale for these 
boundaries is given in the appendix (p 1). A change in 
scores should not be seen for non-painful procedures. 
For each method, a linear mixed model (LMM) was used 
to examine the relationship of change in pain scores 
for painful and non-painful procedures. The LMMs 
examined pain score as a continuous outcome, with 
procedure (painful/non-painful) and assessors treated as 
fixed factors, and infants treated as a random factor 
(appendix p 1).
Responsiveness of the scale for pain was also evaluated 
by grouping infants by score at baseline or preparation 
phase using the PainChek Infant method into those with 
low pain scores (<3) and those with high pain scores (≥3). 
The grouping of infants into low and high pain scores 
using the ObsVAS and percentage NFCS-R and NFCS 
(mean score [ie, sum of items observed divided by sum of 
items visible] multiplied by 100) used a cut-point score of 
See Online for appendix
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50% or higher for the high pain score category and 
scores below 50% for the low pain score category. A LMM 
with pooled session data examined responsiveness using 
pain score as a continuous outcome, with fixed effects 
pain (high or low pain during baseline or preparation), 
procedure (painful or non-painful), session (first or 
second), assessment method, assessors, and infants 
treated as a random factor.
A repeated measures correlation was done to examine 
whether the scales were measuring the same construct, 
using the rmcorr function in RStudio version 1.3.1093 
with 1000 repetition bootstrap 95% CIs reported. We 
considered scales with r>0·75 as measuring the same 
construct. Repeated measures Bland-Altman plots22 were 
used to assess the level of agreement between methods, 
using MedCalc software, version 19.5.3. This procedure 
is based on the calculations described by Zou.23 We 
calculated Z scores from the first testing session, and 
compared Z scores of ObsVAS, NCFS-R multiple, and 
NCFS-R single viewing with PainChek Infant adaptive 
and PainChek Infant standard.
Pain score inter-rater differences were examined 
with ICC with 95% CI separately for testing session, 
method, and video segment. ICC investigations were also 
done separately for assessor type. ICC values were 
interpreted as poor (<0·50), moderate (≥0·50–0·75), good 
(>0·75–0·90), and excellent (>0·90).24 Cronbach alpha was 
used to assess the internal consistency between the four 
assessors for each method with α greater than 0·70 
considered acceptable. Pain scores (ObsVAS, NCFS-R 
multiple, and NCFS-R single) for the first and second 
testing sessions were combined (matching infant video, 
segment, method, and assessor) to examine intra-rater 
differences. Mean pain scores for PainChek Infant video 
adaptive mode, PainChek Infant standard 3 s video mode, 
and PainChek Infant standard 3 s video mode simulated 
First testing session Second testing session
Baseline Preparation During Recovery Baseline Preparation During Recovery
ObsVAS
n 118 118 118 118 120 119 120 120
Mean 1·9% 8·0% 83·0% 23·1% 2·9% 6·8% 81·2% 24·6%
SD 5·5% 17·7% 26·4% 27·8% 8·8% 15·7% 27·9% 27·8%
Median 0% 0% 95% 14·5% 0% 0% 95% 15%
IQR 0–0% 0–10% 80–100% 0–40% 0–0% 0–10% 70–100% 0–40%
NFCS-R multiple*
n 119 119 119 119 120 120 120 119
Mean 7·9% 17·4% 91·2% 40·9% 9·7% 15·6% 92·0% 42·2%
SD 15·5% 28·0% 22·5% 41·0% 17·6% 26·5% 20·5% 41·3%
Median 0% 0% 100% 25% 0% 0% 100% 25%
IQR 0–0% 0–25% 100–100% 0–80% 0–20% 0–20% 100–100% 0–80%
NFCS-R single*
n 120 120 120 120 120 120 120 119
Mean 8·5% 15·0% 90·0% 40·3% 8·5% 14·2% 89·3% 39·5%
SD 16·4% 27·4% 25·1% 40·8% 14·4% 26·2% 25·0% 40·2%
Median 0% 0% 100% 25% 0% 0% 100% 20%
IQR 0–20% 0–20% 100–100% 0–80% 0–20% 0–20% 100–100% 0–80%
PainChek Infant adaptive†
n 115 116 114 114 NA NA NA NA
Mean 10·0% 10·0% 83·3% 25·0% NA NA NA NA
SD 13·3% 15·0% 28·3% 30·0% NA NA NA NA
Median 0% 0% 100% 17% NA NA NA NA
IQR 0–1% 0–1% 4–6% 0–2% NA NA NA NA
PainChek Infant standard†
n 113 115 115 113 37 36 36 35%
Mean 10·0% 11·7% 85·0% 25·0% 10·0% 11·7% 86·7% 28·3%
SD 15·0% 18·3% 28·3% 31·7% 15·0% 20·0% 26·7% 33·3%
Median 0% 0% 100% 17% 0% 0% 100% 17%
IQR 0–1% 0–1% 5–6% 0–2% 0–1% 0–1% 5–6% 0–3%
n=number of assessments. *Scores ranged from 0 to 5 and are presented here as percentage of maximum score. Scores were calculated using only valid datapoints 
(ie, missing datapoints were ignored); however, if all facial features were not visible then the pain score was considered missing. †Scores ranged from 0 to 6 and are presented 
here as percentage of maximum score, and were simulated during the second testing session.
Table 1: Description of pain and distress scores for each video segment, by assessment method, for the first and second testing sessions
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were combined (matching infant video, segment, and 
method) to examine intra-rater differences. All models 
used two-way mixed effects with absolute agreement.
Role of the funding source
The funder of the study is a previous or current employer 
of authors KH, JDH, and PTC who have had a role in 
the study design, data collection, data analysis, data 
interpretation, and writing of the report.
Results
Using 40 individual videos of White infants undergoing 
immunisation, 4303 pain assessments were completed in 
two separate sessions, starting on Aug 31, and Oct 19, 2020. 
Infants were aged 2·2 to 6·9 months, with a mean age of 
3·6 months (SD 1·3) and a median age of 3·4 months 
(IQR 2·3–4·5). 24 (60%) of 40 infants were female. 
2384 assessments were conducted using the five pain 
assessment methods during the first testing session, 
including 119 using NFCS-R multiple, 120 using NFCS-R 
single, 120 using PainChek Infant adaptive, 119 using 
PainChek Infant Standard, and 118 using ObsVAS. All 
assessors completed 30 assessments per video segment 
using each assessment method, apart from one assessor 
who only completed 29 assessments using NFCS-R 
multiple, 29 assessments using PainChek Infant Standard, 
and 28 assessments using ObsVAS Pain scores because 
this assessor failed to save the completed assessments in 
the EDMS before moving to the next set of video segments. 
During the second testing session, 1439 assessments were 
done using three methods (table 1), and an additional 
160 assessments were done by simulation (ie, no assessor) 
independently from the main study using the PainChek 
Infant standard simulator.
The presence of facial action peaked during vaccination, 
and were slightly higher at recovery compared with 
baseline levels, according to PainChek Infant adaptive and 
PainChek Infant standard (first testing session), and 
PainChek Infant standard simulated (second testing 
session; figure 1; appendix p 2). The GLMM indicated 
that there was a significant difference between video 
segments for the presence of each of the facial actions 
(p<0·001; appendix p 2). In the first testing session, across 
all assessments using PainChek Infant adaptive and 
PainChek Infant standard, there were 41 (4%) failures 
out of a total of 956 recorded assessments (including 
21 [4%] failures of 480 assessments using PainChek 
Infant adaptive and 20 [4%] failures of 476 assessments 
Figure 1: Pain score changes for each video segment by assessment method, 
during the first testing session (A), second testing session (B), and combined 
testing session scores (C)
PainChek Infant adaptive and PainChek Infant standard (scored on a scale of 0–6) 
and NFCS-R single and NFCS-R multiple (scored on a scale of scale 0–5) are 
presented here as percentages. The error bars represent 95% CIs. 
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using PainChek Infant standard). Reported failures 
commonly related to poor video quality, posture of the 
child, or obstruction of the child by the nurse or parent. 
Excessive head movement contributed to failure in only 
five occasions. PainChek Infant standard simulated 
recorded 17 (11%) failures out of 160 segment assessments 
attempted. These failures were due to the automatic start 
of the assessment by the system, which meant that the 
assessor was not able to effectively judge the most suitable 
time to start the assessment. For failures, only the single 
segment datapoint was treated as missing, with remaining 
segment datapoints retained in the analysis. The GEE 
analysis reported a significant difference between video 
segments for the presence of facial action frequencies for 
NFCS-R single and NFCS-R multiple (appendix p 3).
The pain scores for each assessment method at each 
video segment are described in table 1 for both testing 
session one and session two. GEE models controlling for 
assessor and video segment did not detect a significant 
difference in pain scores across the two testing sessions, 
using either NFCS-R single (Wald χ²=0·1; p=0·75), 
NFCS-R multiple (Wald χ²=0·1; p=0·78), or ObsVAS 
(Wald χ²=0·8; p=0·39). When the PainChek Infant 
standard simulated data pain scores were compared with 
the mean (across assessors) PainChek adaptive and 
PainChek standard scores controlling for video segment, 
no significant difference was detected between methods 
(Wald χ²=1·3 p=0·51).
We examined the responsiveness of the scales using 
painful and non-painful change scores with LMM results 
described in table 2. All three PainChek Infant methods 
reported a clinically significant change (a change in score 
of more than 2 points) for the painful procedures, 
with the LMM confirming a significant effect for the 
responsiveness to a painful procedure of 4·4 (95% BCa CI 
4·0–4·7) using the PainChek Infant adaptive and the 
PainChek Infant standard methods, and 4·6 (95% BCa CI 
3·7–5·6) using the PainChek Infant standard simulated 
method. Similarly, the NFCS-R and ObsVAS methods 
also reported clinically significant (>33% change) and 
statistically significant responsiveness (table 2; figure 1). 
Responsiveness proportions for each method at baseline 
or preparation indicated a low frequency of infants with 
high pain or distress levels: PainChek Infant adaptive 
recognised nine (4%) of 231 infants having high baseline 
pain or distress levels, PainChek Infant standard 
recognised 13 (6%) of 238, NFCS-R single recognised 
18 (8%) of 240 in the first testing session and 14 (6%) of 
240 in the second, NFCS-R multiple recognised 18 (8%)
of 238 in the first testing session and 18 (8%) of 240 in 
the second, ObsVAS recognised five (2%)of 236 in the 
first testing session and five (2%) of 239 in the second, 
and PainChek Infant standard simulation recognised 
six (8%) of 80. LMM did not detect a significant difference 
in the change in pain scores between those infants 
reporting low pre-vaccination pain or distress compared 
with those reporting high pre-vaccination pain or distress 
(F=1·6; p=0·211).
Repeated measures correlation reported significant 
correlations between PainChek Infant adaptive and the 
following methods: ObsVAS (r=0·88, 95% CI 0·85–0·90; 
p<0·0001), NFCS-R single (r=0·83, 95% CI 0·79–0·86; 
p<0·0001), and NFCS-R multiple (r=0·82, 95% CI 
0·78–0·85; p<0·0001); and between PainChek Infant 
standard and these methods: ObsVAS (r=0·88, 95% CI 
0·86–0·90; p<0·0001), NFCS-R single (r=0·82, 95% CI 
0·79–0·85; p<0·0001), and NFCS-R multiple (r=0·83, 
95% CI 0·79–0·85; p<0·0001; appendix p 4). Repeated 
Painful event Non-painful event Linear mixed model*
Mean SD 95% BCa CI Median IQR Mean SD 95% BCa CI Median IQR β estimate† 95% BCa CI p value
First testing session
ObsVAS 80·3 27·8 74·4 to 85·1 93·5 70 to 100 6·0 18·7 3·1 to 9·5 0·0 0 to 10 74·3 69·2 to 79·4 0·0010
NFCS-R multiple‡ 83·0% 25·5% 78·1 to 87·4% 100·0% 75 to 100% 9·7% 31·0% 4·7 to 15·7% 0·0% 0 to 20% 73·4% 66·7 to 80·9% 0·0010
NFCS-R single‡ 81·4% 28·4% 75·9 to 86·0% 100·0% 75 to 100% 6·4% 29·9% 1·5 to 11·1% 0·0% 0 to 5% 75·0% 68·8 to 82·0% 0·0010
PainChek Infant 
adaptive§
4·6 1·8 4·2 to 4·9 5·0 4 to 6 0·2 1·1 0·0 to 0·4 0·0 0 to 1 4·4 4·0 to 4·7 0·0010
PainChek Infant 
standard§
4·6 1·8 4·2 to 4·9 5·0 4 to 6 0·2 1·1 0·0 to 0·3 0·0 0 to 0 4·4 4·0 to 4·7 0·0010
Second testing session
ObsVAS 78·3 29·1 73·2 to 83·3 94·0 60 to 100 3·9 17·4 1·0 to 6·9 0·0 0 to 5 74·4 68·7 to 79·8 <0·0001
NFCS-R multiple‡ 82·3% 25·9% 77·9 to 86·6% 100·0% 60 to 100% 5·9% 29·1% 0·9 to 10·5% 0·0% 0 to 0% 76·4% 70·0 to 83·3% <0·0001
NFCS-R single‡ 80·7% 28·5% 75·4 to 85·3% 100·0% 60 to 100% 5·7% 28·0% 1·4 to 10·8% 0·0% 0 to 0% 75·0% 68·3 to 82·2% <0·0001
PainChek Infant 
standard simulated§
4·8 1·7 4·2 to 5·5 6·0 5 to 6 0·2 1·4 –0·2 to 0·8 0·0 0 to 1 4·6 3·7 to 5·6 0·0020
BCa CI=bias corrected and accelerated confidence intervals. IQR=interquartile range. NFCS-R=Neonatal Facial Coding System-Revised. ObsVAS=Observer administered Visual Analogue Scale. *Linear mixed 
model includes random effect for infant and fixed effect for assessor with bootstrap estimates. †Compared with non-painful procedure in which parameter is set to 0. ‡Scores ranged from 0 to 5 and change in 
scores are presented here as percentages. §Scores range from 0 to 6. Scores were calculated using only valid datapoints (ie, missing datapoints were ignored), however; if all facial features were not visible then 
the pain score was considered missing.
Table 2: Change in pain scores between painful and non-painful events for each assessment method
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measures Bland-Altman plots for both testing sessions 
found no systematic differences between the compared 
measures (figure 2). For each comparison a mean 
difference of 0·02 was reported (except the comparison 
between NFCS-R multiple and PainChek Infant adaptive, 
which had a mean difference 0·01), all within the 
±1·96 limits of agreement indicating agree ment between 
methods (appendix p 5).
ICC results generally indicated moderate to excellent 
agreement across all assessors for each method and 
segment (table 3). Inter-rater reliability was typically better 
during the vaccination and recovery segments, ranging 
from moderate (NFCS-R multiple at second testing had 
an ICC 95% CI lower bound of 0·51), to excellent (ObsVAS 
and PainChek Infant adaptive at first testing had an ICC 
95% CI upper bound of 0·99). Inter-rater reliability in 
assessing baseline and preparation segments ranged from 
poor (NFCS-R single at second use had an ICC 95% CI 
lower bound of 0·08) to excellent (ObsVAS at first use had 
an ICC 95% CI upper bound of 0·96). PainChek Infant 
adaptive and PainChek Infant standard consistently 
reported moderate to excellent (≥0·81) inter-rater 
Figure 2: Repeated measures Bland-Altman plots for both testing sessions
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agreement across all segments for the first session. 
Internal consistency between assessors (table 3) was 
acceptable for all methods and segments except for first 
testing when assessing the preparation segment for 
NFCS-R single (α=0·63); second testing when assessing 
baseline segment NFCS-R single (α=0·58) and NFCS-R 
multiple (α=0·69), and when assessing preparation 
segment for ObsVAS (α=0·66). PainChek Infant adaptive 
and PainChek Infant standard methods reported high 
values of internal consistency ranging from α=0·82 when 
assessing the baseline segment with PainChek Infant 
adaptive, to α=0·97 when assessing the during vaccination 
segment with PainChek Infant standard.
Intra-rater reliability between the first and second 
testing sessions overall and separated for each video 
segment was excellent for ObsVAS, NFCS-R multiple, 
and NFCS-R single (table 4). Comparison of the three 
PainChek Infant methods reported good-to-excellent 
intra-rater reliability both overall and separated for each 
video segment (table 4).
First testing session Second testing session
Baseline Preparation During Recovery Baseline Preparation During Recovery
ObsVAS
ICC 0·91 0·64 0·97 0·97 0·73 0·62 0·94 0·96
ICC 95%CI 0·81–0·96 0·30–0·84 0·94–0·99 0·93–0·99 0·48–0·88 0·29–0·83 0·88–0·97 0·93–0·99
p value <0·0001 0·0001 <0·0001 <0·0001 <0·0001 0·0008 <0·0001 <0·0001
α 0·91 0·72 0·98 0·97 0·74 0·66 0·94 0·97
NFCS-R multiple
ICC 0·80 0·83 0·91 0·96 0·58 0·76 0·75 0·94
ICC 95% CI 0·59–0·91 0·62–0·93 0·82–0·96 0·92–0·98 0·22–0·81 0·51–0·90 0·51–0·89 0·85–0·98
p value <0·0001 <0·0001 <0·0001 <0·0001 0·0004 <0·0001 <0·0001 <0·0001
α 0·82 0·87 0·91 0·97 0·69 0·82 0·78 0·96
NFCS-R single
ICC 0·67 0·58 0·93 0·93 0·48 0·66 0·89 0·93
ICC 95% CI 0·38–0·85 0·21–0·81 0·85–0·97 0·85–0·97 0·08–0·75 0·35–0·85 0·79–0·95 0·85–0·97
p-value 0·0001 0·0019 <0·0001 <0·0001 0·0057 0·0003 <0·0001 <0·0001
α 0·73 0·63 0·93 0·95 0·58 0·69 0·90 0·95
PainChek Infant adaptive
ICC 0·81 0·83 0·97 0·92 NA NA NA NA
ICC 95% CI 0·61–0·92 0·65–0·93 0·93–0·99 0·83–0·97 NA NA NA NA
p value <0·0001 <0·0001 <0·0001 <0·0001 NA NA NA NA
α 0·82 0·85 0·97 0·92 NA NA NA NA
PainChek Infant standard
ICC 0·87 0·83 0·97 0·94 NA NA NA NA
ICC 95% CI 0·72–0·95 0·66–0·93 0·93–0·99 0·88–0·98 NA NA NA NA
p value <0·0001 <0·0001 <0·0001 <0·0001 NA NA NA NA
α 0·90 0·84 0·97 0·95 NA NA NA NA
α=Cronbach alpha. ICC=intraclass correlation coefficient. NFCS-R=Neonatal Facial Coding System-Revised. ObsVAS=Observer administered Visual Analogue Scale.
Table 3: Inter-rater reliability and internal consistency outcomes for each pain and distress method of assessment at each segment for both testing sessions
ObsVAS NFCS-R multiple NFCS-R single PainChek Infant
ICC ICC 95% CI p value α ICC ICC 95% CI p value α ICC ICC 95% CI p value α ICC ICC 95% CI p value α
Overall 0·98 0·98–0·99 <0·0001 0·98 0·97 0·96–0·97 <0·0001 0·97 0·96 0·96–0·97 <0·0001 0·96 0·99 0·98–0·99 <0·0001 0·99
Baseline 0·85 0·79–0·90 <0·0001 0·86 0·81 0·73–0·87 <0·0001 0·82 0·81 0·73–0·87 <0·0001 0·81 0·93 0·88–0·96 <0·0001 0·93
Preparation 0·95 0·93–0·97 <0·0001 0·95 0·90 0·85–0·93 <0·0001 0·90 0·86 0·80–0·90 <0·0001 0·86 0·84 0·72–0·91 <0·0001 0·84
During 0·94 0·91–0·96 <0·0001 0·94 0·87 0·81–0·91 <0·0001 0·87 0·94 0·92–0·96 <0·0001 0·94 0·98 0·97–0·99 <0·0001 0·98
Recovery 0·95 0·93–0·97 <0·0001 0·95 0·95 0·93–0·97 <0·0001 0·95 0·94 0·91–0·96 <0·0001 0·94 0·97 0·94–0·98 <0·0001 0·97
Intra-rater reliability was based on repeat measures from the first and second testing session for ObsVAS and NFCS-R, whereas intra-rater reliability for PainChek Infant was based on repeat measures from 
Painchek Infant adaptive (first testing session), Painchek Infant standard (first testing session), and Painchek Infant standard simulated (second testing session). α=Cronbach alpha. ICC=intraclass correlation 
coefficient. NFCS-R=Neonatal Facial Coding System-Revised. ObsVAS=Observer administered Visual Analogue Scale.
Table 4: Intra-rater reliability and internal consistency outcomes for each pain and distress method of assessment at each segment
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Discussion
This study evaluated the psychometric properties of 
PainChek Infant compared with the NFCS-R and 
ObsVAS, to determine its suitability of use in the 
assessment of procedural pain in infants. Both com-
parator tools rely on the user to observe and use their 
judgement related to the presence of pain or the intensity 
of the pain or distress being displayed, which could have 
an effect on how pain is treated. These user-reliance 
properties are common in other existing observational 
pain assessment tools. In comparison, PainChek Infant, 
resulting from advances in AI, uses automated facial 
expression analysis to automatically decode the face and 
determine the presence of six pain-related facial 
expressions. PainChek Infant analysis is completed 
without user subjectivity and in real time, in 3 s. 
Additionally, PainChek Infant is operated from a mobile 
device, therefore offering potential benefits in relation to 
workflow, documentation, and communication. Using 
these properties together, PainChek Infant presents an 
opportunity to improve pain assessment in infants, and 
could lead to changes in clinical practice that help to 
address the current challenges around making pain 
visible in the infant population group.5 When compared 
with NFCS-R, PainChek Infant shows similar frequencies 
of recognition of facial actions common to the two scales, 
supporting the similarity of their construct. Furthermore, 
changes in total pain scores across the four video 
segments for PainChek (adaptive and standard), NFCS-R 
(single and multiple), and ObsVAS followed the same 
patterns (figure 1), in line with what would be anticipated 
for infants undergoing immunisation.
Differentiating pain from distress using currently 
available observational pain scales is difficult.25,26 Here, 
we acknowledge the potential for overlap between 
pain and non-pain related distress on infants’ facial 
expressions. Nonetheless, our findings are encouraging 
considering a clear change in facial expressions 
pre-needle and post-needle insertion, starting from the 
baseline through to the recovery. Our findings confirm 
the responsiveness of all three scales to pain intervention, 
as evidenced by clinically and statistically significant 
effect of the painful procedure. This significance is 
support by a study from 2012, in which facial expressions 
similar to those covered by PainChek Infant and NFCS-R 
were analysed in infants aged 2, 4, 6, and 12 months, for 
up to a minute post-needle insertion. The study showed 
that the expressions were associated with pain or pain-
related distress, rather than other emotions such as 
sadness or anger.27 Interestingly, AU25 (parting lips), as 
detected using PainChek Infant, and horizontal mouth 
opening as defined by NFCS-R, were the most common 
features detected in both pre-vaccination segments (ie, at 
baseline and preparation). These two segments occur 
before the painful stimuli (ie, the injection), and so it 
would be reasonable to assume that AU25 is not 
representative of pain-related distress. This finding could 
assist users in differentiating non-pain related facial 
expressions (neutral, positive, or negative) from those of 
pain, especially when no source of potential pain is 
suspected. However, AU25 has been shown to be a 
prominent feature of pain-related distress in infants 
undergoing immunisation across a range of ages, 
occurring together with AU3 or AU4 (brow lowered or 
pulled together), AU6 or AU7 (cheek raised or lower 
eyelid tightening), AU9, AU10, or AU11 (lip raise or 
nasolabial furrow), AU20, AU25, and AU26c, or AU27 
(widely open cry mouth), and AU43 (eyes closed).28 AU4, 
AU9, AU20, AU25, and AU43 are included in PainChek 
Infant together with AU15 (lip corner depressor), which 
was shown to be prominent during pain in the original 
20 facial actions used to code the images and used to 
develop the PainChek Infant algorithms. A 2011 study 
also reported AU15’s association with pain, as adjudged 
by the NFCS.29 NFCS-R recognised facial actions also 
show concordance with these facial actions, specifically 
AU4, AU9, AU20, AU25, and AU43. Hence, both tools 
have clinical utility in verifying and quantifying pain 
when a source of pain is known or suspected.
PainChek Infant showed excellent convergent validity; 
results of PainChek Infant aligned with both NFCS-R 
and ObsVAS. PainChek Infant also exhibited moderate 
to excellent inter-rater reliability across all four video 
segments. Furthermore, its inter-rater reliability was 
comparable to, or better than, the comparator scales: 
NFCS-R and ObsVAS. Strong inter-rater reliability was 
particularly evident for assessments done at baseline 
and during the preparation phase. The internal 
consistency of the two modes of PainChek Infant 
assessment were also shown to be more than acceptable, 
with high α values. The internal consistency for NFCS-R 
after multiple viewings of the video segment were also 
high and comparable with that reported for the Modified 
Behavioural Pain Scale.26 The inter-rater reliability of the 
three tools used was excellent (with overall ICC values 
being ≥0·96), as were the α scores.
Despite the strategies used to mitigate against various 
methodological limitations, some limitations remained. 
For one, there are challenges associated with evaluating 
the psychometric properties of scales in which a gold 
standard does not exist. Assessment is therefore 
dependent on the results from a range of indirect 
measures of validity, all of which have limitations. It is 
not possible to blind the assessors to the circumstances 
surrounding the infant, therefore potentially biasing 
assessors’ scale application. To help overcome this 
potential bias, four assessors (of clinical and non-clinical 
background) were used and, additionally, the EDMS 
employed in the study automatically muted all videos to 
ensure that sound did not affect the assessors’ scores. 
Assessors were also broadly aware of the purpose of the 
study, and although specific details and hypotheses were 
not revealed, this could have influenced their application 
of the scales. Also, establishing the validity of one 
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measure on the basis of correlation with another 
might rely on circular logic, hence the use of multiple 
assessment methods to establish scale validity. To 
further establish the validity of our findings, we used 
PainChek Infant in both standard and adaptive modes, 
therefore conducting assessments using a fixed video 
duration and a minimum number of valid images, and 
we also used NFCS-R in single view and multiple 
viewing scenarios.
With respect to examining the responsiveness of the 
assessments, we found a very low frequency of high pain 
or distress levels at baseline or preparation at both testing 
sessions, and the data were insufficient for statistical 
examination. Although data were pooled to allow respon-
siveness to be examined, the relatively low sample, 
combined with a non-significant result, suggests that 
responsiveness should be further examined with a larger 
sample to confirm responsiveness of the scale. Future 
work is also required to evaluate the specificity of the 
tool, and differences in facial expressions in response to 
similarly intense painful and non-painful distress stimuli 
should be compared; this was beyond the scope of the 
current study.
This study is also limited by the fact that assessors did 
not face the infants directly, but did their assessments 
by viewing video recordings. Although this method of 
assessing pain differs from clinical practice, the use of 
video recordings to validate pain assessment has been 
successfully done before.8,9,25,26 Also, video recording 
allows multiple viewings of the segments (such as in 
the case of NFCS-R and ObsVAS), which has been 
considered a strength.27 Furthermore, we showed that by 
using the PainChek Infant simulator, the results 
obtained by pointing the device at the computer screen 
were comparable to those obtained by presenting the 
videos directly to the software development kit (ie, real 
world processing). Several failures were recorded with 
the simulator system; however, considering that in real 
world use the assessor decides on the best time to 
initiate assessment (eg, at a time when the infant’s face 
is not obstructed) these failures would likely not occur 
in the real world. Every effort has been made to 
minimise the risk of failure of the automated facial 
analysis through innovative design, inbuilt alerts, and 
user training; however, it is acknowledged that failure 
still might occur, and, dependent on the results of trials 
in clinical practice, a manual assessment option might 
need to be added.
The algorithms incorporated in PainChek Infant have 
been trained and validated using images of infants aged 
1–12 months. As such, use of the tool on younger or older 
children is yet to be tested. Furthermore, the infants 
included in the evaluation were all White, and this must 
be considered when using it with infants of other races. 
However, it should be noted that much has been 
written about the universality of facial expressions, and 
existence of common pain expressions.30 Additionally, 
we acknowledge that facial expressions in some infants 
might be absent due to conditions associated with facial 
palsy. In these cases, multidimensional scales would be 
preferred.
In this study we showed that PainChek Infant has good-
to-excellent validity, reliability, and internal consistency 
when compared with the NFCS-R and the ObsVAS. In 
taking only 3 s to complete, removing observer bias 
associated with high exposure to facial expressions of 
pain29 and automating pain assessment, we believe 
PainChek Infant represents a meaningful advance in the 
assessment and monitoring of procedural pain in infants. 
Still, further research is required to evaluate its clinical 
utility in clinical practice.
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